Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Kantonsspital St.Gallen, Sankt Gallen

Columbia University Medical Center, New York

Mayo Clinic Cancer Center, Jacksonville

Hopital Haut Leveque, Pessac

Hospital Universitario de Salamanca, Salamanca

Hospital Universitario Marqués de Valdecilla, Santander

"Institute of Hematology L. A. Seràgnoli, University of Bologna", Bologna

University Hospitals Cleveland Seidman Cancer Center, Cleveland

CHU Lille Service des Maladies du Sang, Lille

CHU ESTAING Service de thérapie Cellulaire et hématologique Clinique, Clermont-Ferrand

Centre hospitalier Lyon Sud, Pierre-Bénite

Mayo Clinic, Phoenix

University Hospital of Ulm, Department of Internal Medicine III, Ulm

CHU de Caen, Caen

National Cancer Institute, Fondazione 'G. Pascale', Naples

VU medisch centrum, Amsterdam

Erasmus MC, Rotterdam

Institut Català d'Oncologia de Barcelona, L'Hospitalet de Llobregat